Skip to content

Evaluation of Clinical Decision Support System for Large Vessel Occlusion Using Brain CT Images

An Open Label, Single-center, Retrospective, Pivotal Study to Evaluate the Efficacy of Clinical Decision Support System for Large Vessel Occlusion Using Brain CT Images

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05572619
Enrollment
479
Registered
2022-10-07
Start date
2022-03-22
Completion date
2022-09-08
Last updated
2022-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Stroke

Brief summary

cELVO is a software that has been pre-learned based on a large vessel occlusion diagnosis model using brain CT images, and clinical decision support system for diagnosing large vessel occlusion by automatically analyzing brain CT images by assisting the medical team. The specific aims of this study are to evaluate efficacy of cELVO compared to the sensitivity and specificity levels of medical team to diagnosis with and without cELVO used.

Interventions

DEVICE1st Reading

The medical team visually checks the non-contrast CT without cELVO and diagnose the large vessel occlusion.

DEVICE2nd Reading

The medical team visually checks the non-contrast CT with assistance from the cELVO and diagnose the large vessel occlusion.

Sponsors

Heuron Inc.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_CROSSOVER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults over 19 years old * Brain non-contrast CT, CT perfusion and CT angiography acquired * Positive group: A patient diagnosed with large vessel occlusion after a non-contrast CT, CT perfusion and CT angiography * Negative group: A normal person or a patient not diagnosed with large vessel occlusion after a non-contrast CT, CT perfusion and CT angiography

Exclusion criteria

* Poor or incomplete brain non-contrast CT, CT perfusion and CT angiography quality

Design outcomes

Primary

MeasureTime frameDescription
Sensitivity and specificity of medical team compared with/without cELVOWithin 2 weeks after completion of readingSensitivity and specificity of determining large vessel occlusion of medical team when using cELVO compared to not using cELVO

Secondary

MeasureTime frameDescription
Accuracy of medical team compared with/without cELVOWithin 2 weeks after completion of readingAccuracy of determining large vessel occlusion of medical team when using cELVO compared to not using cELVO
ROC Curve for medical team compared with/without cELVOWithin 2 weeks after completion of readingROC Curve of determining large vessel occlusion of medical team when using cELVO compared to not using cELVO
AUC values for medical team compared with/without cELVOWithin 2 weeks after completion of readingAUC values of determining large vessel occlusion of medical team when using cELVO compared to not using cELVO
Sensitivity and specificity of each reader compared with/without cELVOWithin 2 weeks after completion of readingSensitivity and specificity of determining large vessel occlusion of each reader when using cELVO compared to not using cELVO
Sensitivity and specificity of cELVOWithin 2 weeks after completion of readingSensitivity and specificity of cELVO in diagnosis of large vessel occlusion based on golden standards

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026